Azenta Inc
XMUN:BA3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Azenta Inc (BA3) under the Base Case is 27.02 EUR per share.
Compared with the current market price of 43.2 EUR, the stock appears
Overvalued by 37% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Azenta Does
Azenta Inc. sells tools and services that help life science customers store, track, move, and analyze biological samples. Its core products include automated sample storage systems, lab automation equipment, cryogenic storage, and the software and consumables needed to manage those samples safely. It also offers genomic and sequencing services for research and clinical work.
- Headquarters
- United States of America US
- Employees
- 2 900
- IPO date
- Feb 2, 1995
Balance Sheet
Recent Events
Latest Earnings Call
Azenta’s fiscal 2027 plan centers on more consistent execution, organic growth and margin expansion, while integrating new genomic capabilities and working to improve Automated Stores.
What management delivered: 1 better than forecast
Open the earnings call- EPS
- $0.28
- Expected
- $0.11
- Surprise
- +154.5%
- Stock, day of the call
- +20.8%
Azenta insiders are selling less than usual
Past 12 months
Continue BA3 Research
Decided on Azenta? Get an email when BA3 reaches the price you’d buy at. Free with an account.
Other Azenta listings
What is the Intrinsic Value of one BA3 stock?
The intrinsic value for
Azenta Inc (BA3) under the Base Case is 27.02 EUR.
Is BA3 stock undervalued or overvalued?
Compared with the current market price of 43.2 EUR, the stock appears Overvalued by 37% .